RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia-Reference-Cited by-同舟云学术

RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia

Published:2017-08 Issue: Volume:332 Page:180-199
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Rajagopal Lakshmi,Kwon Sunoh,Huang Mei,Michael Eric,Bhat Laxminarayan,Cantillon Marc,Meltzer Herbert Y.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference89 articles.

1. Pharmacotherapy of cognition in schizophrenia;Meltzer;Curr. Opin. Behav. Sci.,2015

2. Novel dopamine therapeutics for cognitive deficits in schizophrenia;Arnsten;Biol. Psychiatry,2016

3. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors;Bubenikova-Valesova;Neurosci. Biobehav. Rev.,2008

4. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia;Meltzer;Int. J. Neuropsychopharmacol.,2013

5. Developing treatments for cognitive deficits in schizophrenia: the challenge of translation;Young;J. Psychopharmacol. (Oxf.),2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Compounds in the Treatment of Schizophrenia—A Selective Review;Brain Sciences;2023-08-11

2. Repeated administration of rapastinel produces exceptionally prolonged rescue of memory deficits in phencyclidine-treated mice;Behavioural Brain Research;2022-08

3. Antipsychotic Agents;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

4. In situ-gelling starch nanoparticle (SNP)/O-carboxymethyl chitosan (CMCh) nanoparticle network hydrogels for the intranasal delivery of an antipsychotic peptide;Journal of Controlled Release;2021-02

5. Oxidative stress biomarkers in treatment-responsive and treatment-resistant schizophrenia patients;Trends in Psychiatry and Psychotherapy;2021